The Pros and Cons of Genomic Markers for Biopsy Guidance
John W. Davis, MD, discusses the benefits and limitations of utilizing genomic markers for prostate biopsy guidance. While genomic markers may not be reliable risk stratification tools alone, they may play a role in risk-refining certain populations and providing information beyond clinical parameters.
Read More